Development and validation of a prediction model using molecular marker for long‐term survival in unresectable stage III non‐small cell lung cancer treated with chemoradiotherapy

BACKGROUND: This study aimed to establish a predictive nomogram integrating epidermal growth factor receptor (EGFR) mutation status for 3‐ and 5‐year overall survival (OS) in unresectable/inoperable stage III non‐small cell lung cancer (NSCLC) treated with definitive chemoradiotherapy. METHODS: A to...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yufan, Zhang, Tao, Zhou, Zongmei, Liang, Jun, Chen, Dongfu, Feng, Qinfu, Xiao, Zefen, Hui, Zhouguang, Lv, Jima, Deng, Lei, Wang, Xin, Wang, Wenqing, Wang, Jianyang, Liu, Wenyang, Zhai, Yirui, Wang, Jie, Bi, Nan, Wang, Luhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807329/
https://www.ncbi.nlm.nih.gov/pubmed/34927371
http://dx.doi.org/10.1111/1759-7714.14218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807329/
https://www.ncbi.nlm.nih.gov/pubmed/34927371
http://dx.doi.org/10.1111/1759-7714.14218

Ejemplares similares